Intra-Cellular Therapies
ITCI
$73.26
Share price
1.57%
Change (1 day)
20.02%
Change (1 year)
Categories
Intra-Cellular Therapies (ITCI) - Total assets
Total assets on the balance sheet as of December 2023 : $0.72 B
According to Intra-Cellular Therapies's latest financial reports the company's total assets are $0.72 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Intra-Cellular Therapies - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.72 B | -3.51% |
| 2022-12-31 | $0.75 B | 54.06% |
| 2021-12-31 | $0.48 B | -31.7% |
| 2020-12-31 | $0.71 B | 185.57% |
| 2019-12-31 | $0.25 B | -29.68% |
| 2018-12-31 | $0.35 B | -24.24% |
| 2017-12-31 | $0.47 B | 21.23% |
| 2016-12-31 | $0.38 B | -19.67% |
| 2015-12-31 | $0.48 B | 269.23% |
| 2014-12-31 | $0.13 B | 241% |
| 2013-12-31 | $38.44 M | 93.96% |
| 2013-03-31 | $0 M | |
| 2012-12-31 | $19.82 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | $0.95 B | 30.81% | 🇺🇸 USA |
 MediciNova MNOV | $66.27 M | -90.90% | 🇺🇸 USA |
 Curis CRIS | $77.28 M | -89.39% | 🇺🇸 USA |